Data & Analytics
However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
Most physicians said EHRs have negatively impacted their communication with a patients.
The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.
BMS and Pfizer outspent Johnson & Johnson two-to-one in advertising for their oral anticoagulant last year.
Judges praised Wunderman Health and GSK for their agility in reacting to dynamic information and creating segment-specific messaging for nasal spray allergy treatment Flonase.
A tracking poll conducted by the Kaiser Family Foundation also found that fewer Americans are seeing prescription drug ads compared to last year.
Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines
Discovering Meaningful Insights in Patient Journeys: Identifying Hidden Patterns Using Advanced AnalyticsSeptember 21, 2016
During this seminar, attendees will learn how advanced data analytics can be applied to gain a measurable competitive advantage.
In this webcast, TrialCard VP of analytic services Paul LeVine and senior analytic consultant Robert Leedom underscore how affordability programs provide the ideal venue for focusing on adherence issues.
In this sponsored podcast, MM&M's Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
A new government investigation found that most but not all prices for generic drugs dispensed by Medicare Part D fell from 2010 to 2015.
Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.
Jawbone data shows that people mentioning Pokémon Go in their comments have been walking 62.5% more than usual.
Mergers and acquisitions targeting digital and data capabilities increased 60% to $1 billion in the first half of 2016.
IBM to help analyze data about the spread of Zika; Grassley to investigate Part D program; Lilly CEO to retire
Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger
Healthcare marketing is evolving more rapidly than ever before — and not surprisingly, the demand for smarter media campaign measurement is increasing as a result.
A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.
The ability to pair data with a story or a human emotion is often easier for women.
Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.
Only 55% of the surveyed pharmaceutical executives said they are adopting digital as a key strategy in R&D.
BIO report finds success rate in Phase-I is 10%; Dunsire departs Forum after failed trials; the FDA issues two warning letters
Two recent polls paint a complicated picture of the public's opinion of the pharma industry.
Keytruda's survival benefit is reinforced by new study; drugmakers reference patient-assistance programs in debate over drug prices; China cuts drug prices
A 69% majority of healthcare organizations said they believe their industry is more vulnerable to data breaches than other business sectors.
Learn more about the top therapeutic categories by sales, top companies by revenue, top drugs by sales, and more.
"Social can enable a better starting point to yield better questions and thus make surveys less in number yet greater in value."
The move away from a fee-for-service reimbursement model and the arrival of promising new technology have created demand for big data in healthcare.
- Lilly's branded app for Trulicity looks to address adherence
- Lawmakers cut CME exemption from 21st Century Cures Act
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Five things for pharma marketers to know: Wednesday, November 30, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Five things for pharma marketers to know: Tuesday, December 6, 2016
- Rock Health's Bill Evans on finding a career with meaning
- Matt Brown leaves Guidemark Health after merger falls through
- Five things for pharma marketers to know: Monday, December 5, 2016
- Prescription drug spending rises 9% in 2015, to $324 billion